Malley Thomas bought KNSA
August 13, 2025 · Form 4 insider transaction
Malley Thomas bought 20,129 shares of Kiniksa Pharmaceuticals International, plc at $10.36 per share, a transaction worth $208.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
20,129
Price
$10.36
Total value
$208.5K
InsiderMalley Thomas
RoleDirector
SecurityClass A Ordinary Shares
Transaction codeM: Option exercise
Transaction dateAugust 13, 2025
Filing dateAugust 14, 2025
Shares owned after32,675
OwnershipDirect
10b5-1 planNo
AmendedNo